Main Menu

getmembership

eurosider  
Inserm logo klein logo aides 2 orig kleuren logo 3 

A Safer Injecting Drugs Education Research to reduce HIV/HCV risk transmission in people who inject drugs

 

About

Eurosider is an European project, financed by the European Union DG Home programme,  supporting initiatives in the field of drugs policy and operates 2018 – 2019.

The project is developed by the French Research Institute INSERM and supported by Aides, France and the Correlation Network.

The INSERM  research institut is internationally known in the field of addiction and public health. The team has coordinated many studies among PWID, the MANIF2000 cohort of 500 HIV-infected injecting drug users, the ANRS-AERLI project which led to validate individually-tailored support and education for safer injection (ITSESI) interventions and is currently evaluating a new harm reduction service that just opened in France, the drug consumption rooms.

AIDES is a national, community-based association fighting HIV and Hepatitis, mobilising over a thousand volonteers and salaried militants. AIDES was a central partner in the ANRS-AERLI research. It is, amongst others, involved in needle exchange programmes, community testing and outreach actitivities as well as research and  advocacy work at local, national and international levels (e.g. via the Coalition Internationale Sida – PLUS).

Correlation– the European Network for Social Inclusion & Health -  works on capacity building, harm reduction, monitoring and advocacy on European level and coordinates the Hepatitis C Initiative and the International Network on Drug Consumption Rooms.

The four local partners have long standing experiences in the field of harm reduction policy and practice  and have the capacity to promote outcomes of the intervention on a national level:

Logo ARAS R lg.en logo praksis Logo GAT Novo Logo
Aras, Romania Initiative for Health, Bulgaria Praksis, Greece GAT, Portugal

 

Background

Access to needle syringe programs (NSP) and to opioid substitution treatment (OST) is well known to reduce unsafe HIV/HCV transmission practices and seroconversion in people who inject drugs (PWID). However, in certain contexts, this access is limited or inadequate, leading to many drug injection-related complications (e.g. HIV and HCV infections, abscesses, cellulitis and other skin infections).

In order to reduce these risks, an individually-tailored educational intervention for safer injection, provided by peer educators, nurses and trained social workers will be implemented in the 4 partner countries Bulgaria, Greece, Portugal and Romania.

The educational intervention has already been validated in the French context for harm reduction programs after showing a significant reduction in unsafe HIV/HCV transmission practices and local complications at injection sites. The project proposed here aims to transfer the French intervention to other contexts (outreach, semi-urban environment, other countries with less access to prevention and care) and more particularly to study the feasibility and the effectiveness of its implementation at a European level.

See here more information about the French intervention
(http://fr.ap-hm.fr/sites/default/files/files/Corevih/corevih_aerli_nov_2017_proux.pdf)
(https://sesstim.univ-amu.fr/projet/aerli)

 

Objectives

The main objective of the Eurosider Project is to contribute to a better  Hepatitis C policy and practice by developing the transferability of an effective community-based intervention to people who inject drugs in different political contexts with the aim to reduce the risk of HIV-HCV transmission.

The individually-tailored support and education for safer injection (ITSESI) intervention consists in offering educational supervision of the different injection phases, from pre- to post-injection and in providing tailored education for each risky act, prevention messages related to HIV/HCV transmission and information about access to screening and care for HIV and HCV.

To achieve these objective, the project partners will:

  • assess the national and local context of services working in the area of HIV/HCV prevention
  • implement and evaluate the ITSESI intervention to reduce risks of (re)infection for PWID’s in Bucharest, Sofia, Athens and Lisbon harm reduction services
  • prepare and disseminate validated tools for effective HIV/HCV risk reduction under PWID’s
  • advocate on policy level for implementation of these ITSESI tools.

 

Outputs

The project will produce a number of tools and publications to disseminate, promote and support the implementation of the method.  Targetgroups include addiction, care and prevention services, drug user groups and associations,  national policy maker and European agencies such as EMCDDA. In particular, the project will:

  • Produce a European training manual, which will be developed based on the evaluation of the ITSESI implementation in the four countries, and directed at field workers and peers with a view to increasing their HCV prevention capacities.
  • Produce scientific publications based on the outcomes of the evaluation of the implementation in the four countries, directed at European stakeholders including researchers, policy makers and policy implementers, in order to increase their awareness and knowledge about the efficacy of ITSESI in harm reduction.
  • Organize a European workshop to promote the (cost) effectiveness of ITSESI and to discuss opportunities for and barriers to implementing the intervention on a wider scale in other European countries. A workshop report will address the main outcomes and recommendations to further advocate the intervention.

 

 meeting team bucharest

Meeting team Bucharest

 

Eurosider publications

Promotional leaflet

Assessment report

Training Manual

Scientific Publication

 

Eurosider events

Eurosider meetings

Eurosider trainings

European workshop

 

euCo-funded by the European Union   

 

 

 


 

 

 

Correlation projects

logo csidp website

seen logo erasmus

eurosider

logo betrad

 

street support

 

logo attune

 


dcr final mini




nps



movelogo ss

   
fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans fake ray bans